{"DataElement":{"publicId":"2816476","version":"1","preferredName":"Pharmacokinetics Preparative Regimen Medication Dose Assessment Specify Text","preferredDefinition":"The free-text field to describe the drug that pharmacokinetics were performed on to determine dosing.","longName":"2816465v1.0:2799057v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2816465","version":"1","preferredName":"Pharmacokinetics Preparative Regimen Medication Dose Assessment","preferredDefinition":"The characteristic movements of drugs within biological systems, as affected by absorption, distribution, binding, elimination, biotransformation, and excretion; particularly the rates of such movements._The chemotherapy and/or radiation given to blood, marrow or cord blood transplant patients prior to transplant to kill diseased cells and/or make space for healthy new marrow and/or suppress the immune system so graft rejection does not occur._A drug or medicine that treats or prevents or alleviates the symptoms of disease._A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time._The final result of a determination of the value, significance, or extent of.","longName":"2816462v1.0:2971612v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2751994","version":"1","preferredName":"Pharmacokinetics","preferredDefinition":"The characteristic movements of drugs within biological systems, as affected by absorption, distribution, binding, elimination, biotransformation, and excretion; particularly the rates of such movements.","longName":"C15299","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pharmacokinetics","conceptCode":"C15299","definition":"The characteristic movements of drugs within biological systems, as affected by absorption, distribution, binding, elimination, biotransformation, and excretion; particularly the rates of such movements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DDF198E-B7E3-2C9D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-22","endDate":null,"createdBy":"UMLLOADER_LEADS","dateCreated":"2008-05-23","modifiedBy":"ONEDATA","dateModified":"2008-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3028375","version":"1","preferredName":"Preparative Regimen Medication Dose Assessment","preferredDefinition":"The chemotherapy and/or radiation given to bone marrow transplant patients prior to transplant to kill diseased cells and/or make space for healthy new marrow and/or suppress the immune system so graft rejection does not occur.:biologically active substance, including those intended for use in diagnosis, treatment, or prevention of disease or other abnormalities, for the relief of suffering, or control or improvement of a physical or mental state; includes biological products.:The amount of medicine taken, or radiation given, at one time.:Having determined the value, significance, or extent of.","longName":"C61155:C459:C25488:C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Preparative Regimen","conceptCode":"C61155","definition":"The chemotherapy or radiation given prior to blood, marrow, cord blood transplant, or cell infusion to kill diseased cells and make space for the healthy new graft and/or suppress the immune system so rejection does not occur.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Medication","conceptCode":"C459","definition":"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8223B6A1-97DB-C0E8-E040-BB89AD43538F","latestVersionIndicator":"Yes","beginDate":"2010-03-19","endDate":null,"createdBy":"LOHNESC","dateCreated":"2010-03-19","modifiedBy":"ONEDATA","dateModified":"2010-03-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5E2CC7C4-1C8C-4D3B-E040-BB89A6436990","latestVersionIndicator":"Yes","beginDate":"2008-12-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2008-12-16","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".Updated def for prep reg, no version needed. AK 12/20/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2799057","version":"1","preferredName":"Specify Text","preferredDefinition":"Be specific about something; define clearly._Text; the words of something written.","longName":"SPC_TXT","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2799056","version":"1","preferredName":"Specify Text","preferredDefinition":"Specify; be specific about something; define clearly.:Text; the words of something written.","longName":"C25685:C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B6FE321-D89B-66BC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-11","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-11","modifiedBy":"ONEDATA","dateModified":"2008-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B6FE321-D8AC-66BC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-11","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-11","modifiedBy":"MALUMK","dateModified":"2021-01-19","changeDescription":"03/17/10-Added CSI for F2000-CJL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964872","version":"1","longName":"2000r1: Recipient Baseline Data","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"prep_reg_phrmk_oth_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"MaterialName:name ","type":"HCT_BRIDG","context":"NHLBI"},{"name":"base_pre_HCT_prep_pharmaco_oth_drug_spec","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Specify other drug pharmacoki","type":"Preferred Question Text","description":"Specify other drug pharmacokinetics performed on to determine dosing:","url":null,"context":"NHLBI"},{"name":"Specify other drug:","type":"Alternate Question Text","description":"Specify other drug:","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2816476","type":"BRIDG Mapping Path","description":"PerformedDiagnosis > PerformedSubstanceAdministration [treatment] > Drug > MaterialName.name WHERE PerformedSubstanceAdministration [treatment] > Subject > PerformedSubstanceAdministration.reasonCode [testing] = \"determine dosing\" AND PerformedSubstanceAdministration [testing] > DefinedSubstanceAdministration.nameCode = \"Administer pharmacokinetics\"","url":null,"context":"NHLBI"},{"name":"Specify other drug:","type":"Application Standard Question Text","description":"Specify other drug:","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5E2CC7C4-1D78-4D3B-E040-BB89A6436990","latestVersionIndicator":"Yes","beginDate":"2008-12-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2008-12-16","modifiedBy":"ALEYR","dateModified":"2019-04-07","changeDescription":".ASQT added. AK 9/6/13 Added alt name for 2000. AK 10/3/13.12/20/13mn-updated prep reg def. no version needed. semantically the same. (dec already updated). Added human readable def. System generated def displayed as alt def. No version needed. AK 11/12/14","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}